Geneticure Patents

Patent portfolio assigned to Geneticure (verified via public assignee records). Estimated patent count: 5. Pharmacogenomic hypertension testing. Multiple Google Patents under assignee Geneticure LLC/Inc. (US10590485B2, US11761043B2, US12351873B2, WO2015183938A1; BioSpace confirms a granted renal-denervation patent). patent_count_estimate is a visible-count lower bound. No named customers found; competitor ClarityX named as a hypertension genetic-test alternative.